Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 41,826 |
|
|||||
| News | - | ||||||
| Day High | 28.12 | Low High |
|||||
| Day Low | 27.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Morphic Holding Inc | MORF | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -0.18% | 27.46 | 11:02:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.39 | 27.26 | 28.12 | 27.51 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,024 | 41,826 | $ 27.44 | $ 1,147,871 | - | 19.345 - 63.0825 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:02:34 | 90 | $ 27.46 | USD |
Morphic Holding Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.38B | 50.04M | - | 521k | -152.1M | -3.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Morphic News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MORF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.01 | 30.01 | 27.24 | 28.41 | 471,008 | -2.55 | -8.50% |
| 1 Month | 34.72 | 35.56 | 27.24 | 30.69 | 388,365 | -7.26 | -20.91% |
| 3 Months | 29.61 | 41.47 | 27.24 | 34.54 | 500,875 | -2.15 | -7.26% |
| 6 Months | 21.04 | 41.47 | 19.345 | 29.39 | 540,993 | 6.42 | 30.51% |
| 1 Year | 43.66 | 63.0825 | 19.345 | 35.96 | 685,661 | -16.20 | -37.10% |
| 3 Years | 54.82 | 68.75 | 19.23 | 36.78 | 410,867 | -27.36 | -49.91% |
| 5 Years | 18.00 | 93.00 | 9.90 | 37.92 | 305,048 | 9.46 | 52.56% |
Morphic Description
| Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. |
